Faculty & Staff Directory
- Senior Associate Dean, College of Science
- Chief Scientific Officer, Center for Infectious Disease Research
Ph.D., University of California, (UCLA)
Dr. Andalibi has served as the Interim Dean and Associate Dean for Research in the College of Science at George Mason University. He received his PhD from the Department of Microbiology and Molecular Genetics at UCLA and later joined the faculty in the Department of Medicine in UCLA. Subsequently, he was involved in several early stage biotechnology companies. He then joined the House Ear Institute (HEI) as the Director of New Technology and Project Development and held a joint appointment in the Department of Otolaryngology at the University of Southern California, School of Medicine.
As a public servant Dr. Andalibi has served as a Program Director in the National Science Foundation’s Division of Industrial Innovation and Partnerships, where he oversaw the NSF’s medical biotechnology SBIR/STTR grant portfolio and at the National Cancer Institute, where he served as the head of the Therapeutics and Diagnostics Section in the NCI’s SBIR Development Center.
Dr. Andalibi is a molecular biologist and geneticist by training, with a very broad, multidisciplinary background that includes nearly three decades of research into the genetics and molecular mechanisms of metabolic and inflammatory diseases. The focus of his research has been on the elucidation of the role of the inflammatory process, including identification of inflammation-induced signal transduction pathways and the role of innate immune molecules in the etiology of diseases such as atherosclerosis, diabetes, otitis media, and neurofibromatosis.
- Andalibi A, Saddique A, Koizumi N. (In Press) Assessment of SARS-CoV-2 Transmission Among Attendees of Live Concert Events in Japan Using Contact Tracing Data. J Travel Med.
- Shah AP, Shen JI, Wang Y, Tong L, Pak Y, Andalibi A, La Page JA, Adler SG. Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy. PLoS One. 2016 Mar 28;11(3):e0152357. doi: 10.1371/journal.pone.0152357.
- Mehrian-Shai R, Freedman S, Shams S, Doherty J, Slattery W, Hsu NY, Reichardt JK, Andalibi A, Toren A. Schwannomas exhibit distinct size-dependent gene-expression patterns. Future Oncol. 2015;11(12):1751-8. doi: 10.2217/fon.15.72.
- Dai T, Wang Y, Nayak A, Nast CC, Quang L, LaPage J, Andalibi A, Adler SG. Janus kinase signaling activation mediates peritoneal inflammation and injury in vitro and in vivo in response to dialysate. Kidney Int. 2014 Jul 9. doi:10.1038/ki.2014.209. [Epub ahead of print] PubMed PMID: 25007168.
- Toren A, Reichardt JK, Andalibi A, Hsu NY, Doherty J, Slattery W, Mehrian-Shai. R. Novel age-dependent targets in vestibular schwannomas. Hum Genomics. 2014 Jun 30;8:10.